Takeda Pharmaceutical Co Ltd ADR
Price & Volume
Stats
See more52W Range | $12.77-$18.90 |
Market Cap | $56.3B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $4.6T |
Revenue Growth (YoY) | 10.2% |
Gross Profit (12 Mos) | $2.9T |
Diluted EPS | -$0.33 |
News
See moreYahoo Finance • 4 days ago
Takeda Pharmaceutical (TSE:4502) Wins ORZEYFUL Approval, Where Does Fair Value Sit?
Yahoo Finance • 5 days ago
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
Yahoo Finance • 9 days ago
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance • 10 days ago
Takeda Wins FDA Nod For ORZEYFUL, First Orexin Therapy For Narcolepsy Type 1
About
CEO | Ms. Julie Kim |
CFO | Mr. Milano Furuta |
Address | 1-1, Nihonbashi-Honcho 2-chome, Chuo, Japan, 103-8668 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 47,029 |